Clinical Trial Update: Study of Adsorption Tetanus-diphtheria-acellular Pertussis (DTaP) Vaccine in Healthy 3 to 5 Months Infants [Phase 3]

View source ↗

Summary

Phase 3 study completion update for an adsorbed DTaP vaccine in healthy 3- to 5-month-old infants tested for pertussis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pertussis

Drugs mentioned

• DTaP Vaccine, Adsorbed (diphtheria and tetanus toxoids and acellular pertussis vaccine, adsorbed)

Snippet

Sponsor: Jiangsu Province Centers for Disease Control and Prevention | Conditions: Pertussis | Phase 3 | Status: COMPLETED